These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23282556)

  • 1. [Prophylaxis against Chagas disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
    Benítez R; Noemí I; Tassara R; Catalán P; Avilés CL
    Rev Chilena Infectol; 2012 Sep; 29 Suppl 1():S41-3. PubMed ID: 23282556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prophylaxis against Toxoplasma gondii disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
    Payá E; Noemí I; Tassara R; Catalán P; Avilés CL
    Rev Chilena Infectol; 2012 Sep; 29 Suppl 1():S37-9. PubMed ID: 23282555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylaxis against cytomegalovirus infection in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
    Ferrés M; Nervi B; Ramírez P
    Rev Chilena Infectol; 2012 Sep; 29 Suppl 1():S23-8. PubMed ID: 23282552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chagas disease in the immunosuppressed host.
    Bern C
    Curr Opin Infect Dis; 2012 Aug; 25(4):450-7. PubMed ID: 22614520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prophylaxis against Epstein Barr disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
    Catalán P; Alba A
    Rev Chilena Infectol; 2012 Sep; 29 Suppl 1():S29-31. PubMed ID: 23282553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nifurtimox, a bright future for treatment of Chagas disease].
    Wolf A; Boulliat C; Coillot C; Rouault M; Gaillard K; Beranger C; Oliver M
    Med Trop (Mars); 2011 Apr; 71(2):131-3. PubMed ID: 21695868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of Trypanosoma cruzi infection in the indeterminate phase: experience and current guidelines in Argentina].
    Sosa Estani S; Segura EL
    Medicina (B Aires); 1999; 59 Suppl 2():166-70. PubMed ID: 10668259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylaxis against tuberculosis in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
    Lafourcade M
    Rev Chilena Infectol; 2012 Sep; 29 Suppl 1():S45-7. PubMed ID: 23282557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylaxis against respiratory viral disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
    Álvarez AM; Catalán P; Alba A; Zubleta M
    Rev Chilena Infectol; 2012 Sep; 29 Suppl 1():S33-6. PubMed ID: 23282554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Part VI. Antiparasitic treatment for Chagas disease].
    B WA; G IH; L MI; M LJ; V PM; H IN; V AM; P JS; H MT; A IZ
    Rev Chilena Infectol; 2008 Oct; 25(5):384-9, discussion 387. PubMed ID: 18949153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of Chagas disease chemotherapy.
    Guedes PM; Silva GK; Gutierrez FR; Silva JS
    Expert Rev Anti Infect Ther; 2011 May; 9(5):609-20. PubMed ID: 21609270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nifurtimox chemotherapy: collateral effects in treated Trypanosoma cruzi infected patients.
    Murcia L; Carrilero B; Albajar Viñas P; Segovia M
    Rev Esp Quimioter; 2012 Mar; 25(1):74-5. PubMed ID: 22488545
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitrypanosomal therapy for chronic Chagas' disease.
    Bern C
    N Engl J Med; 2011 Jun; 364(26):2527-34. PubMed ID: 21714649
    [No Abstract]   [Full Text] [Related]  

  • 14. American trypanosomiasis (Chagas disease).
    Rassi A; Rassi A; Marcondes de Rezende J
    Infect Dis Clin North Am; 2012 Jun; 26(2):275-91. PubMed ID: 22632639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chagas disease and immunodeficiency: HIV infection and transplantation].
    Le Loup G; Ibrahim K; Malvy D
    Bull Soc Pathol Exot; 2009 Dec; 102(5):310-8. PubMed ID: 20131425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of Chagas' disease: cutaneous manifestations in two immunosuppressed patients.
    Riganti J; Maqueda MG; Piñero MC; Volonteri VI; Galimberti RL
    Int J Dermatol; 2012 Jul; 51(7):829-34. PubMed ID: 22715827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance and safety of nifurtimox in patients with chronic chagas disease.
    Jackson Y; Alirol E; Getaz L; Wolff H; Combescure C; Chappuis F
    Clin Infect Dis; 2010 Nov; 51(10):e69-75. PubMed ID: 20932171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chagas disease: Present status of pathogenic mechanisms and chemotherapy.
    Maya JD; Orellana M; Ferreira J; Kemmerling U; López-Muñoz R; Morello A
    Biol Res; 2010; 43(3):323-31. PubMed ID: 21249304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi: a novel chemical class (nitrobenzofurans) active against infections of mice (Mus musculus).
    Kinnamon KE; Poon BT; Hanson WL; Waits VB
    Exp Parasitol; 1998 Jun; 89(2):251-6. PubMed ID: 9635449
    [No Abstract]   [Full Text] [Related]  

  • 20. Recognizing and meeting the challenge of Chagas disease in the USA.
    Bowling J; Walter EA
    Expert Rev Anti Infect Ther; 2009 Dec; 7(10):1223-34. PubMed ID: 19968514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.